This result was further validated by immunohistochemistry (IHC) analysis of DUSP3 protein expression in human lung cancer tissues from Cohort 2 TMA, which included well-differentiated, moderately differentiated, and poorly differentiated lung tumors. This evidence concerns the gene DUSP3 and lung cancer.